Rovin BH - Search Results

1

The impact of tabalumab on the kidney in systemic lupus erythematosus: results from two phase 3 randomized, clinical trials.

Rovin BH, Dooley MA, Radhakrishnan J, Ginzler EM, Forrester TD, Anderson PW. Rovin BH, et al. Lupus. 2016 Dec;25(14):1597-1601. doi: 10.1177/0961203316650734. Epub 2016 May 24. Lupus. 2016. PMID: 27220348 Clinical Trial.

2

D-dimer level and the risk for thrombosis in systemic lupus erythematosus.

Wu H, Birmingham DJ, Rovin B, Hackshaw KV, Haddad N, Haden D, Yu CY, Hebert LA. Wu H, et al. Clin J Am Soc Nephrol. 2008 Nov;3(6):1628-36. doi: 10.2215/CJN.01480308. Clin J Am Soc Nephrol. 2008. PMID: 18945994 Free PMC article.

3

Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.

Appel GB, Contreras G, Dooley MA, Ginzler EM, Isenberg D, Jayne D, Li LS, Mysler E, Sánchez-Guerrero J, Solomons N, Wofsy D; Aspreva Lupus Management Study Group. Appel GB, et al. J Am Soc Nephrol. 2009 May;20(5):1103-12. doi: 10.1681/ASN.2008101028. Epub 2009 Apr 15. J Am Soc Nephrol. 2009. PMID: 19369404 Free PMC article. Clinical Trial.

4

Random spot urine protein/creatinine ratio is unreliable for estimating 24-hour proteinuria in individual systemic lupus erythematosus nephritis patients.

Hebert LA, Birmingham DJ, Shidham G, Rovin B, Nagaraja HN, Yu CY. Hebert LA, et al. Nephron Clin Pract. 2009;113(3):c177-82. doi: 10.1159/000232599. Epub 2009 Aug 12. Nephron Clin Pract. 2009. PMID: 19672116 Free PMC article.

5

Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial.

Ginzler EM, Wofsy D, Isenberg D, Gordon C, Lisk L, Dooley MA; ALMS Group. Ginzler EM, et al. Arthritis Rheum. 2010 Jan;62(1):211-21. doi: 10.1002/art.25052. Arthritis Rheum. 2010. PMID: 20039429 Free article. Clinical Trial.

6

The complex nature of serum C3 and C4 as biomarkers of lupus renal flare.

Birmingham DJ, Irshaid F, Nagaraja HN, Zou X, Tsao BP, Wu H, Yu CY, Hebert LA, Rovin BH. Birmingham DJ, et al. Among authors: rovin bh. Lupus. 2010 Oct;19(11):1272-80. doi: 10.1177/0961203310371154. Epub 2010 Jul 6. Lupus. 2010. PMID: 20605879 Free PMC article.

7

Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q.

Mok CC, Birmingham DJ, Ho LY, Hebert LA, Song H, Rovin BH. Mok CC, et al. Among authors: rovin bh. Lupus. 2012 Jan;21(1):36-42. doi: 10.1177/0961203311422094. Epub 2011 Oct 12. Lupus. 2012. PMID: 21993384

8

Discrepancies in glomerular and tubulointerstitial/vascular immune complex IgG subclasses in lupus nephritis.

Satoskar AA, Brodsky SV, Nadasdy G, Bott C, Rovin B, Hebert L, Nadasdy T. Satoskar AA, et al. Lupus. 2011 Nov;20(13):1396-403. doi: 10.1177/0961203311416533. Lupus. 2011. PMID: 22095887

9

Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans.

Birmingham DJ, Hebert LA, Song H, Noonan WT, Rovin BH, Nagaraja HN, Yu CY. Birmingham DJ, et al. Among authors: rovin bh. Lupus. 2012 Jul;21(8):855-64. doi: 10.1177/0961203312439640. Epub 2012 Mar 20. Lupus. 2012. PMID: 22433915 Free PMC article.

10

The value of repeat kidney biopsy in quiescent Argentinian lupus nephritis patients.

Alvarado AS, Malvar A, Lococo B, Alberton V, Toniolo F, Nagaraja HN, Rovin BH. Alvarado AS, et al. Among authors: rovin bh. Lupus. 2014 Jul;23(8):840-7. doi: 10.1177/0961203313518625. Epub 2014 Jan 8. Lupus. 2014. PMID: 24401872

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

312 results

Search Page